Delving the Role of Caralluma fimbriata: An Edible Wild Plant to Mitigate the Biomarkers of Metabolic Syndrome
Open Access
- 1 January 2022
- journal article
- review article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5720372
Abstract
Metabolic syndrome (MS), commonly known as syndrome X or insulin resistance syndrome, is a collection of risk factors for cardiovascular diseases and type II diabetes. MS is believed to impact over a billion individuals worldwide. It is a medical condition defined by visceral obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels, according to the World Health Organization. The current dietary trends are more focused on the use of functional foods and nutraceuticals that are well known for their preventive and curative role against such pathological disorders. Caralluma fimbriata is one such medicinal plant that is gaining popularity. It is a wild, edible, succulent roadside shrub with cactus‐like leaves. Besides its main nutrient contents, various bioactive constituents have been identified and linked with positive health outcomes of appetite‐suppressing, hypolipidemic, antioxidant, hepatoprotective, and anticancer potentials. Hence, such properties make C. fimbriata an invaluable plant against MS. The current review compiles recent available literature on C. fimbriata’s nutritional composition, safety parameters, and therapeutic potential for MS. Summarized data in this review reveals that C. fimbriata remains a neglected plant with limited food and therapeutic applications. Yet various studies explored here do prove its positive health‐ameliorating outcomes.Keywords
This publication has 83 references indexed in Scilit:
- A review on ethnobotany, phytochemistry and pharmacology of plant genus C aralluma R. BrJournal of Pharmacy and Pharmacology, 2014
- Evaluation of cellular antioxidant activity of selected species of Caralluma and Boucerosia on cell linesInternational Journal of Applied Sciences and Biotechnology, 2014
- Beneficial effects of hydro-alcoholic extract of Caralluma fimbriata against high-fat diet-induced insulin resistance and oxidative stress in Wistar male ratsJournal of Physiology and Biochemistry, 2014
- Safety Assessment of a Hydroethanolic Extract of Caralluma fimbriataInternational Journal of Toxicology, 2013
- A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trialComplementary Therapies in Medicine, 2013
- Antioxidant capacity and amino acid analysis of Caralluma adscendens (Roxb.) Haw var. fimbriata (wall.) Grav. & Mayur. aerial partsJournal of Food Science and Technology, 2012
- Tannins, Peptic Ulcers and Related MechanismsInternational Journal of Molecular Sciences, 2012
- Pharmacological Review of Caralluma R.Br. with Special Reference to Appetite Suppression and Anti-ObesityJournal of Medicinal Food, 2012
- Antioxidant and Hypolipidemic Effect of Caralluma adscendens Roxb. in Alloxanized Diabetic RatsInternational Journal of Pharmacology, 2010
- Pregnane Glycosides from Caralluma adscendens var. fimbriataChemistry & Biodiversity, 2008